About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

UNKNOWNPhase 1/2NCT05474950

Minocycline Treatment for Cystoid Macular Edema

Cystoid macular edema (CME) is one of sight-threatening, immune-related ocular diseases. The efficacy of current treatments for CME (anti-VEGF, glucocorticoids and other agents) are limiting. Minocycl...

Lead sponsor: Sun Yat-sen University•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Sun Yat-sen University

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Participant diagnosed with CME.
•Participant aged from 18-60 years old.
•Participant that signed the informed consent document and is able to complete the following visits.

Exclusion Criteria

•Participant is allergy to minocycline or tetracyclines.
•Participant has no contraindications of minocycline or tetracyclines.
•Participant has an abnormal function of liver, heart, kidney and thyroid.
•Female that is pregnant, breast-feeding or planning to become pregnant.
•Participant that is currently using other medications.

Related studies

RECRUITINGPhase 4

The PRIME Study: A Randomized, Controlled, Prospective Study

NCT04549935 · Patient Preference, Patient Outcomes, and more

COMPLETEDPhase 4

Assessing eFficacy and Safety of DEXTENZA 0.4 mg inseRt, Following Cataract Surgery

NCT05626478 · Corneal Edema, Corneal Defect, and more

COMPLETEDPhase 4

Scaling and Root Planing (SRP) With and Without Minocycline HCl Microspheres, 1 mg

NCT03762915 · SRP, Minocycline HCl Microspheres, and more

WITHDRAWNPhase 3

Intravitreal Bevacizumab (Avastin) for Pseudophakic Macular Edema (PME)

NCT00406172 · Cystoid Macular Edema

COMPLETEDPhase 1

Neuroimmune Dysfunction in Alcohol Use Disorder

NCT04210713 · Alcohol Drinking, Alcohol-Related Disorders, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 19, 2023Terms

Trial snapshot

StatusUNKNOWN

PhasePHASE1/PHASE2

Enrollment5

Start dateJan 2019

Last updatedApr 19, 2023

Condition

Minocycline Cystoid Macular Edema

Locations shown

Zhongshan Ophthalmic Center

Guangzhou, Guangdong

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 19, 2023Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions